Cao, Jie
Zhang, Xiaosong
Shahinian, Vahakn
Yin, Huiying
Steffick, Diane
Saran, Rajiv
Crowley, Susan
Mathis, Michael http://orcid.org/0000-0002-9697-2212
Nadkarni, Girish N. http://orcid.org/0000-0001-6319-4314
Heung, Michael
Singh, Karandeep http://orcid.org/0000-0001-8980-2330
Funding for this research was provided by:
U.S. Department of Veterans Affairs (36C10B18C2766, 36C10B18C2766, 36C10B18C2766, 36C10B18C2766, 36C10B18C2766, 36C10B18C2766, 36C10B18C2766)
Article History
Received: 10 May 2022
Accepted: 11 October 2022
First Online: 1 December 2022
Competing interests
: K.S.’s institution receives grant funding from Teva Pharmaceuticals and Blue Cross Blue Shield of Michigan for unrelated work, and K.S. serves on an advisory board for Flatiron Health. M.M. has received research grants from the US National Institutes of Health (NHLBI K01HL141701). G.N.N. is also supported by R01DK108803, U01HG007278, U01HG009610 and 1U01DK116100. G.N.N. reports personal income and equity and stock options from Renalytix and pulseData. G.N.N. is a scientific cofounder of Renalytix, Verici Dx, Pensieve Health, Nexus Health Connect and Data2Wisdom and owns equity in these companies. G.N.N. has received personal income from Siemens Healthineers, Variant Bio, AstraZeneca, Reata, BioVie, Daiichi Sankyo, Cambridge Health Consulting, Qiming Capital and GLG Consulting in the past three years. M.H. receives research grant funding from Astute Medical Inc. and Spectral Medical Inc., and serves as a consultant for Wolters-Kluwer Inc., Potrero Inc. and CardioSounds Inc. The remaining authors declare no competing interests.